| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aetiology and prevention of emesis induced by radiotherapy
|
Feyer, P. C.
|
|
1998
|
6 |
3 |
p. 253-260
|
artikel
|
| 2 |
Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics
|
Morrow, G. R.
|
|
1998
|
6 |
3 |
p. 244-247
|
artikel
|
| 3 |
Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting
|
Spitzer, T. R.
|
|
1998
|
6 |
3 |
p. 233-236
|
artikel
|
| 4 |
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy
|
Gandara, D. R.
|
|
1998
|
6 |
3 |
p. 237-243
|
artikel
|
| 5 |
Consensus regarding multiple day and rescue antiemetic therapy
|
De Mulder, P. H. M.
|
|
1998
|
6 |
3 |
p. 248-252
|
artikel
|
| 6 |
Corticosteroids, dopamine antagonists and other drugs
|
Herrstedt, J.
|
|
1998
|
6 |
3 |
p. 204-214
|
artikel
|
| 7 |
Delayed emesis following anticancer chemotherapy
|
Kris, M. G.
|
|
1998
|
6 |
3 |
p. 228-232
|
artikel
|
| 8 |
Epicutaneous breast forms
|
Münstedt, K.
|
|
1998
|
6 |
3 |
p. 295-299
|
artikel
|
| 9 |
Introduction
|
Tonato, M.
|
|
1998
|
6 |
3 |
p. 193
|
artikel
|
| 10 |
Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity
|
Hesketh, P. J.
|
|
1998
|
6 |
3 |
p. 221-227
|
artikel
|
| 11 |
Neuropharmacology of emesis and its relevance to anti-emetic therapy
|
Andrews, P. L. R.
|
|
1998
|
6 |
3 |
p. 197-203
|
artikel
|
| 12 |
Oncology Home Care Service
|
Hafenbrack, A.
|
|
1998
|
6 |
3 |
p. 195-196
|
artikel
|
| 13 |
Optimal selection of antiemetics in children receiving cancer chemotherapy
|
Roila, F.
|
|
1998
|
6 |
3 |
p. 215-220
|
artikel
|
| 14 |
Palliative care of cancer patients: audit of current hospital procedures
|
Sessa, C.
|
|
1998
|
6 |
3 |
p. 266-272
|
artikel
|
| 15 |
Predictive factors for psychological distress in ambulatory lung cancer patients
|
Akechi, Tatsuo
|
|
1998
|
6 |
3 |
p. 281-286
|
artikel
|
| 16 |
Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes
|
Spanik, S.
|
|
1998
|
6 |
3 |
p. 291-294
|
artikel
|
| 17 |
Prevention of Pneumocystis carinii pneumonia with cotrimoxazole 18 mg/kg
|
Postma, A.
|
|
1998
|
6 |
3 |
p. 300
|
artikel
|
| 18 |
Prospective study of bacteraemia in cancer patients
|
Escande, M. C.
|
|
1998
|
6 |
3 |
p. 273-280
|
artikel
|
| 19 |
Psycho-oncology and supportive care: an interview with Darius Razavi
|
,
|
|
1998
|
6 |
3 |
p. 194
|
artikel
|
| 20 |
Statistical considerations in the design, conduct and analyses of antiemetic clinical trials
|
Morrow, G. R.
|
|
1998
|
6 |
3 |
p. 261-265
|
artikel
|
| 21 |
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support
|
Climent, M. A.
|
|
1998
|
6 |
3 |
p. 287-290
|
artikel
|
Tijdschrift beschrijving